KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Novavax (NVAX) over the last 17 years, with Q3 2025 value amounting to $1.3 billion.

  • Novavax's Total Liabilities fell 4030.33% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year decrease of 4030.33%. This contributed to the annual value of $2.2 billion for FY2024, which is 1313.06% down from last year.
  • According to the latest figures from Q3 2025, Novavax's Total Liabilities is $1.3 billion, which was down 4030.33% from $1.3 billion recorded in Q2 2025.
  • Novavax's 5-year Total Liabilities high stood at $3.0 billion for Q2 2022, and its period low was $1.3 billion during Q2 2025.
  • For the 5-year period, Novavax's Total Liabilities averaged around $2.3 billion, with its median value being $2.3 billion (2024).
  • In the last 5 years, Novavax's Total Liabilities skyrocketed by 34575.71% in 2021 and then plummeted by 4227.91% in 2025.
  • Novavax's Total Liabilities (Quarter) stood at $2.9 billion in 2021, then dropped by 1.22% to $2.9 billion in 2022, then dropped by 13.08% to $2.5 billion in 2023, then fell by 13.13% to $2.2 billion in 2024, then crashed by 38.81% to $1.3 billion in 2025.
  • Its Total Liabilities stands at $1.3 billion for Q3 2025, versus $1.3 billion for Q2 2025 and $1.4 billion for Q1 2025.